TGF-beta antagonists: why suppress a tumor suppressor?
- PMID: 12070299
- PMCID: PMC151022
- DOI: 10.1172/JCI15970
TGF-beta antagonists: why suppress a tumor suppressor?
Figures
Comment on
-
Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.J Clin Invest. 2002 Jun;109(12):1551-9. doi: 10.1172/JCI15234. J Clin Invest. 2002. PMID: 12070302 Free PMC article.
-
Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.J Clin Invest. 2002 Jun;109(12):1607-15. doi: 10.1172/JCI15333. J Clin Invest. 2002. PMID: 12070308 Free PMC article.
References
-
- Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet. 2001;29:117–129. - PubMed
-
- Akhurst RJ, Derynck R. TGF-β signaling in cancer: a double-edged sword. Trends Cell Biol. 2001;11:S44–S51. - PubMed
-
- Wakefield LM, Roberts AB. TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev. 2002;12:22–29. - PubMed
-
- Kakonen, S.M., et al. 2002. TGFβ stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J. Biol. Chem. In press. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
